Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 27,466 | 9,287 | 5,490 | 1,245 | 14,941 |
| Gross Profit | 27,466 | 9,287 | 5,490 | 1,245 | 14,941 |
| Operating Expenses | 54,018 | 50,787 | 57,639 | 54,470 | 58,653 |
| Operating Income | -26,552 | -41,500 | -52,149 | -53,225 | -43,712 |
| Interest Expense | 357 | 796 | 1,245 | 713 | 0 |
| Other Income | 807 | 1,622 | 2,661 | 928 | 46 |
| Pre-tax Income | -26,102 | -40,674 | -50,733 | -53,010 | -43,666 |
| Income Tax | 500 | N/A | N/A | N/A | 495 |
| Net Income Continuous | -26,602 | -40,674 | -50,733 | -53,010 | -44,161 |
| Net Income | $-26,602 | $-40,674 | $-50,733 | $-53,010 | $-44,161 |
| EPS Basic Total Ops | -0.28 | -0.72 | -1.11 | -1.49 | -1.41 |
| EPS Basic Continuous Ops | -0.28 | -0.72 | -1.11 | -1.49 | -1.41 |
| EPS Diluted Total Ops | -0.28 | -0.72 | -1.11 | -1.49 | -1.41 |
| EPS Diluted Continuous Ops | -0.28 | -0.72 | -1.11 | -1.49 | -1.41 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.72 | -1.11 | -1.49 | -1.41 |
| EBITDA(a) | $-25,769 | $-41,066 | $-51,790 | $-52,593 | $-42,459 |